Pembrolizumab for Early Triple-Negative Breast Cancer

Queen Mary University of London, Instituto Oncológico Dr. Rosell, Vall d'Hebron Institute of Oncology, Yale Cancer Center, Cedars-Sinai Medical Center, Kliniken Essen-Mitte, Karolinska University Hospital, Karolinska Institutet, Philipps University of Marburg, Samsung Medical Center, Sungkyunkwan University, The University of Sydney, Westmead Hospital, Westmead Institute, Breast Center, Ludwig-Maximilians-Universität München, National Hospital Organization Hokkaido Medical Center, Sapporo National Hospital, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Champalimaud Foundation, Helios Hospital Berlin-Buch, Merck & Co., Inc., Rahway, NJ, USA (United States), National University of Singapore, Duke-NUS Medical School, National Cancer Centre Singapore, Texas Oncology, Baylor University Medical Center